{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:31:03Z","timestamp":1752550263157,"version":"3.41.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.therap.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:25:20Z","timestamp":1725938720000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retinal vascular occlusion after COVID-19 vaccination: Analysis of the French pharmacovigilance database"],"prefix":"10.1016","volume":"80","author":[{"given":"Mathilde","family":"Beurrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Bapiste","family":"Conart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Lauren","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Facile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras-Champel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-3178","authenticated-orcid":false,"given":"Nadine","family":"Petitpain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2024.08.002_bib0305","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/ijo.IJO_297_21","article-title":"COVID-19 and eye: a review of ophthalmic manifestations of COVID-19","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0310","unstructured":"Glacet-Bernard A, Creuzot-Garcher C, Massin P. \u0152d\u00e8me maculaire des occlusions veineuses. Soci\u00e9t\u00e9 fran\u00e7aise d\u2019ophtalmologie. 2016. https:\/\/www.em-consulte.com\/em\/SFO\/2016\/html\/file_100022.html [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0315","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jfo.2022.09.008","article-title":"Acute macular neuroretinopathy and COVID-19 vaccination: Case report and literature review","volume":"46","author":"Fekri","year":"2023","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0320","unstructured":"EMA European Medicine Agency. Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the meeting on 25\u201328 October 2021. https:\/\/www.ema.europa.eu\/ 2022. https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-prac-meeting-25-28-october-2021_en.pdf [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0325","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1007\/s10792-021-01971-2","article-title":"Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine","volume":"41","author":"Bialasiewicz","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0330","doi-asserted-by":"crossref","first-page":"672","DOI":"10.18240\/ijo.2022.04.24","article-title":"Phenotypic appearance of central retinal vein occlusion post AstraZeneca vaccine","volume":"15","author":"Cackett","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0335","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/kjm2.12591","article-title":"Combined central retinal artery occlusion and vein occlusion with exudative retinal detachment following COVID-19 vaccination","volume":"38","author":"Chen","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.therap.2024.08.002_bib0340","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4103\/ijo.IJO_1477_21","article-title":"Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report","volume":"69","author":"Endo","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0345","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4103\/ijo.IJO_2412_21","article-title":"Unilateral retinal vein occlusion in a young, healthy male following Sputnik V vaccination","volume":"69","author":"Goyal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0350","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.4103\/ijo.IJO_592_22","article-title":"Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature","volume":"70","author":"Dutta Majumder","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0355","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.4103\/ijo.IJO_1927_22","article-title":"Retinal venous occlusion in a child following Corbevax COVID-19 vaccination","volume":"70","author":"Nangia","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/ICB.0000000000001214","article-title":"Central retinal vein occlusion following BNT162B2 (Pfizer BioNtech) COVID-19 messenger RNA vaccine","volume":"17","author":"Shah","year":"2023","journal-title":"Retin Cases Brief rep"},{"key":"10.1016\/j.therap.2024.08.002_bib0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/vaccines11020365","article-title":"Central retinal vein occlusion in a young woman with diabetes and hypertension after mRNA-based COVID-19 vaccination\u2014A case report and brief review of the literature","volume":"11","author":"Sung","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.therap.2024.08.002_bib0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12348-022-00311-4","article-title":"Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination \u2013 can it be explained by the two-hit hypothesis?","volume":"12","author":"Parakh","year":"2022","journal-title":"J Ophthal Inflamm Infect"},{"key":"10.1016\/j.therap.2024.08.002_bib0375","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1080\/09273948.2022.2079534","article-title":"COVID-19 adenoviral vector vaccine and central retinal vein occlusion","volume":"30","author":"Romano","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.therap.2024.08.002_bib0380","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40123-021-00441-3","article-title":"Retinal vein occlusion following two doses of mRNA-1237 (Moderna) immunization for SARS-Cov-2: A case report","volume":"11","author":"Sacconi","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.therap.2024.08.002_bib0385","first-page":"e25842","article-title":"Central retinal vein occlusion following the first dose of COVID vaccine","volume":"14","author":"Sodhi","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.therap.2024.08.002_bib0390","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijo.IJO_1757_21","article-title":"Central retinal vein occlusion post-COVID-19 vaccination","volume":"70","author":"Sonawane","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0395","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ceo.14056","article-title":"Retinal vein occlusion following COVID-19 vaccination","volume":"50","author":"Peters","year":"2022","journal-title":"Clin Exp Ophtalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0400","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/09273948.2022.2094811","article-title":"Possible COVID-19 MRNA vaccine-induced case of unilateral central retinal vein occlusion","volume":"31","author":"Takacs","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.therap.2024.08.002_bib0405","doi-asserted-by":"crossref","first-page":"NP121","DOI":"10.1177\/11206721221124651","article-title":"Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine","volume":"33","author":"Karageorgiou","year":"2023","journal-title":"Eur J Ophtalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0410","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/vaccines9111349","article-title":"Retinal vascular events after mRNA and adenoviral-vectored COVID-19 vaccines\u2014A case series","volume":"9","author":"Girbardt","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.therap.2024.08.002_bib0415","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000521838","article-title":"Branch retinal vein occlusion after messenger RNA-based COVID-19 vaccine","volume":"13","author":"Sugihara","year":"2022","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0420","doi-asserted-by":"crossref","first-page":"e28236","DOI":"10.1097\/MD.0000000000028236","article-title":"Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination: Case reports","volume":"100","author":"Tanaka","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.therap.2024.08.002_bib0425","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/tjo.tjo_24_22","article-title":"Branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination","volume":"12","author":"Tanaka","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0430","doi-asserted-by":"crossref","first-page":"101540","DOI":"10.1016\/j.ajoc.2022.101540","article-title":"Ischemic retinal events after COVID-19 vaccination","volume":"26","author":"Priluck","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.therap.2024.08.002_bib0435","doi-asserted-by":"crossref","first-page":"101445","DOI":"10.1016\/j.ajoc.2022.101445","article-title":"Branch retinal vein occlusion in a healthy young man following mRNA COVID-19 vaccination","volume":"26","author":"Pur","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.therap.2024.08.002_bib0440","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jfma.2022.07.002","article-title":"Central retinal artery occlusion after Moderna mRNA-1273 vaccination","volume":"121","author":"Chow","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.therap.2024.08.002_bib0445","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2147\/OPTH.S357359","article-title":"Branch retinal artery occlusions, paracentral acute middle maculopathy and acute macular neuroretinopathy after COVID-19 vaccinations","volume":"16","author":"Ishibashi","year":"2022","journal-title":"Clin Ophtalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0450","doi-asserted-by":"crossref","first-page":"845615","DOI":"10.3389\/fphar.2022.845615","article-title":"Case report: recanalization of branch retinal artery occlusion due to microthrombi following the first dose of SARS-CoV-2 mRNA vaccination","volume":"13","author":"Kang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.therap.2024.08.002_bib0455","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.4103\/ijo.IJO_1148_22","article-title":"Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV-2 vaccine Covaxin","volume":"70","author":"Thakar","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0460","doi-asserted-by":"crossref","first-page":"101430","DOI":"10.1016\/j.ajoc.2022.101430","article-title":"Central retinal artery occlusion following COVID-19 vaccine administration","volume":"26","author":"Abdin","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.therap.2024.08.002_bib0465","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/qjmed\/hcab287","article-title":"Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination","volume":"114","author":"Ikegami","year":"2022","journal-title":"QJM"},{"key":"10.1016\/j.therap.2024.08.002_bib0470","first-page":"7","article-title":"Combined central retinal artery and vein occlusion with ischemic optic neuropathy after COVID-19 vaccination","volume":"15","author":"Lee","year":"2022","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.therap.2024.08.002_bib0475","unstructured":"ANSM. Liste des centres r\u00e9gionaux de pharmacovigilance. 2023. https:\/\/ansm.sante.fr\/page\/liste-des-centres-regionaux-de-pharmacovigilance [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0480","unstructured":"ANSM. Enqu\u00eate de pharmacovigilance du vaccin VAXZEVRIA\u00ae Rapport no 12 : p\u00e9riode du 07 mai 2021 au 20 mai 2021. CRPV d\u2019Amiens - CRPV de Rouen. 2021. https:\/\/ansm.sante.fr\/uploads\/2021\/05\/28\/20210528-covid-19-vaccins-astrazeneca-rapport-12-07-05-2021-20-05-2021-2.pdf [Accessed 5 September 2024 (38 pp.)]."},{"key":"10.1016\/j.therap.2024.08.002_bib0485","unstructured":"EMA European Medicine Agency. COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine's benefits currently still outweigh risks - Update. 2021. https:\/\/www.ema.europa.eu\/en\/news\/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits-currently-still-outweigh-risks-update [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0490","unstructured":"ANSM. Bonnes pratiques de pharmacovigilance. 2020. https:\/\/ansm.sante.fr\/documents\/reference\/bonnes-pratiques-de-pharmacovigilance [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0495","unstructured":"EMA. Good pharmacovigilance practices. European Medicines Agency 2018. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/pharmacovigilance\/good-pharmacovigilance-practices [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0500","unstructured":"AMELI. Les donn\u00e9es de la vaccination contre la Covid-19. 2023. https:\/\/datavaccin-covid.ameli.fr\/pages\/type-vaccins\/ [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0505","doi-asserted-by":"crossref","first-page":"e0269268","DOI":"10.1371\/journal.pone.0269268","article-title":"Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study","volume":"17","author":"Kan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2024.08.002_bib0510","unstructured":"Our World in Data. Coronavirus (COVID-19) Vaccinations. 2024. https:\/\/ourworldindata.org\/covid-vaccinations [Accessed 5 September 2024]."},{"key":"10.1016\/j.therap.2024.08.002_bib0515","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/j.jfo.2022.05.006","article-title":"Bilateral retinal vein occlusion after two doses of SARS-CoV-2 adenovirus vector-based vaccine","volume":"45","author":"Fern\u00e1ndez-Vigo","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0520","first-page":"62","article-title":"Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases","volume":"26","author":"Granel","year":"1997","journal-title":"Presse Med"},{"key":"10.1016\/j.therap.2024.08.002_bib0525","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S0140-6736(96)91112-5","article-title":"Occlusion of central retinal vein after hepatitis B vaccination","volume":"347","author":"Devin","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2024.08.002_bib0530","first-page":"1","article-title":"Ocular adverse events after influenza vaccination in older adults: self-controlled case series using a large database in Japan","volume":"31","author":"Hashimoto","year":"2023","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.therap.2024.08.002_bib0535","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/jcm12041325","article-title":"Bilateral branch retinal vein occlusion after mRNA-SARS-CoV-2 booster dose vaccination","volume":"12","author":"Gironi","year":"2023","journal-title":"JCM"},{"key":"10.1016\/j.therap.2024.08.002_bib0540","doi-asserted-by":"crossref","first-page":"102898","DOI":"10.1016\/j.amsu.2021.102898","article-title":"Central retinal vein occlusion in patients with COVID-19 infection: A systematic review","volume":"71","author":"Ullah","year":"2021","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.therap.2024.08.002_bib0545","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/meajo.meajo_271_21","article-title":"Central retinal vein occlusion in a young healthy COVID-19 patient: A case report and literature review","volume":"28","author":"Al-Abri","year":"2021","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0550","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaophthalmol.2022.0632","article-title":"Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis","volume":"140","author":"Modjtahedi","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0555","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2024.08.002_bib0560","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.3390\/jcm11175101","article-title":"Retinal vascular occlusion after COVID-19 vaccination: More coincidence than causal relationship? Data from a retrospective multicentre study","volume":"11","author":"Feltgen","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.therap.2024.08.002_bib0565","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/s41433-023-02459-2","article-title":"Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series","volume":"37","author":"Pellegrini","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.therap.2024.08.002_bib0570","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s00417-022-05707-5","article-title":"Retinal vascular occlusion and SARS-CoV-2 vaccination","volume":"260","author":"Vujosevic","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0575","doi-asserted-by":"crossref","first-page":"e2021048","DOI":"10.4084\/MJHID.2021.048","article-title":"A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: Ophthalmic vein thrombosis following Covid","volume":"13","author":"Panovska-Stavridis","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.therap.2024.08.002_bib0580","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2024.08.002_bib0585","doi-asserted-by":"crossref","first-page":"e9255","DOI":"10.1097\/MD.0000000000009255","article-title":"Cardiovascular risk factors in patients with combined central retinal vein occlusion and cilioretinal artery occlusion: Case report","volume":"97","author":"Grzybowski","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.therap.2024.08.002_bib0590","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.4103\/ijo.IJO_2116_19","article-title":"Combined retinal vascular occlusion: Demography, clinical features, visual outcome, systemic co-morbidities, and literature review","volume":"68","author":"Raval","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0595","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5935\/0004-2749.20220017","article-title":"Vascular retinal findings after COVID-19 vaccination in 11 cases: a coincidence or consequence?","volume":"85","author":"Silva","year":"2022","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.therap.2024.08.002_bib0600","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/IAE.0000000000003371","article-title":"Myths and truths of the assocation of retinal vascular occlusion with COVID-19","volume":"42","author":"Sharma","year":"2022","journal-title":"Retina"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:14:56Z","timestamp":1747761296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595724000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0040595724000982"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2024.08.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal vascular occlusion after COVID-19 vaccination: Analysis of the French pharmacovigilance database","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}